Halyard Health (HYH) Upgraded to “Overweight” by KeyCorp

KeyCorp upgraded shares of Halyard Health (NYSE:HYH) from a sector weight rating to an overweight rating in a research note released on Thursday morning, MarketBeat.com reports.

A number of other brokerages have also issued reports on HYH. ValuEngine upgraded shares of Halyard Health from a hold rating to a buy rating in a research note on Wednesday, February 28th. Zacks Investment Research lowered shares of Halyard Health from a buy rating to a hold rating in a research note on Wednesday, January 3rd. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company currently has an average rating of Buy and an average price target of $49.33.

How to Become a New Pot Stock Millionaire

NYSE:HYH traded up $0.98 on Thursday, reaching $46.43. 441,177 shares of the company’s stock were exchanged, compared to its average volume of 410,573. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.98 and a quick ratio of 2.74. The firm has a market capitalization of $2,110.93, a PE ratio of 20.08, a price-to-earnings-growth ratio of 5.27 and a beta of 1.62. Halyard Health has a 52-week low of $35.24 and a 52-week high of $50.99.

Halyard Health (NYSE:HYH) last issued its quarterly earnings results on Tuesday, February 27th. The medical instruments supplier reported $0.73 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.23. The company had revenue of $428.10 million for the quarter, compared to analyst estimates of $413.94 million. Halyard Health had a net margin of 5.82% and a return on equity of 6.98%. The business’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.50 earnings per share. analysts expect that Halyard Health will post 0.96 EPS for the current fiscal year.

Several hedge funds have recently added to or reduced their stakes in HYH. LPL Financial LLC purchased a new stake in shares of Halyard Health during the fourth quarter worth approximately $206,000. Jane Street Group LLC purchased a new stake in shares of Halyard Health during the third quarter worth approximately $211,000. Xact Kapitalforvaltning AB purchased a new position in Halyard Health in the fourth quarter valued at approximately $250,000. Ramsey Quantitative Systems purchased a new position in Halyard Health in the fourth quarter valued at approximately $266,000. Finally, ING Groep NV increased its stake in Halyard Health by 23.2% in the fourth quarter. ING Groep NV now owns 7,060 shares of the medical instruments supplier’s stock valued at $326,000 after purchasing an additional 1,329 shares during the last quarter. Hedge funds and other institutional investors own 91.32% of the company’s stock.

WARNING: “Halyard Health (HYH) Upgraded to “Overweight” by KeyCorp” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at https://www.tickerreport.com/banking-finance/3335788/halyard-health-hyh-upgraded-to-overweight-by-keycorp.html.

Halyard Health Company Profile

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Zacks: MAM Software Group  Given $8.50 Consensus Target Price by Analysts
Zacks: MAM Software Group Given $8.50 Consensus Target Price by Analysts
Advanced Disposal  Receives Consensus Rating of “Hold” from Analysts
Advanced Disposal Receives Consensus Rating of “Hold” from Analysts
Herc Holdings Inc.  Receives Average Recommendation of “Hold” from Analysts
Herc Holdings Inc. Receives Average Recommendation of “Hold” from Analysts
Freshpet  vs. General Mills  Head to Head Analysis
Freshpet vs. General Mills Head to Head Analysis
Critical Survey: Qurate Retail Group  versus Its Peers
Critical Survey: Qurate Retail Group versus Its Peers
Financial Survey: Telia  versus Its Rivals
Financial Survey: Telia versus Its Rivals


© 2006-2018 Ticker Report. Google+.